Last October the 10th, EBERS signed a distribution agreement in Japan with the firm AR Brown ( AR Brown is a leading Japanese company with commercial activity in a variety of sectors including chemicals, pharmaceuticals, automobile, aerospace and biotechnology. With this new agreement, EBERS gains access to the thriving regenerative medicine market in Japan.